Miles Berger, MD PhD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction (NCT03802396) | Miles Berger, MD PhD | 2018-07-15 |
Track Miles Berger, MD PhD automatically
Every clearance here is in the API, with alerts when new ones post.